on 21 July 2009
In a major advance in obesity and diabetes research, Yale School of Medicine scientists have found that reducing levels of a key enzyme in the brain decreased appetites and increased energy levels. Reductions in the levels of the enzyme prolylcarboxypeptidase (PRCP) led to weight loss and a decreased risk of type 2 diabetes in mice, according to research published in the August issue of The Journal of Clinical Investigation.
Read more: Obesity / Weight Loss / Fitness News From Medical News Today
Yale Discovery May Open Door To Drug That Cuts Appetite And Boosts Energy posted under Weight loss News
